Intellia Therapeutics Inc (NTLA)
21.38
-0.72
(-3.26%)
USD |
NASDAQ |
May 31, 16:00
21.38
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics Accounts Payable (Quarterly): 13.69M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 13.69M |
December 31, 2023 | 7.452M |
September 30, 2023 | 3.553M |
June 30, 2023 | 11.63M |
March 31, 2023 | 6.89M |
December 31, 2022 | 5.154M |
September 30, 2022 | 4.384M |
June 30, 2022 | 7.515M |
March 31, 2022 | 10.14M |
December 31, 2021 | 9.653M |
September 30, 2021 | 7.47M |
June 30, 2021 | 6.854M |
March 31, 2021 | 8.688M |
December 31, 2020 | 10.46M |
September 30, 2020 | 7.775M |
June 30, 2020 | 0.007M |
March 31, 2020 | 3.87M |
Date | Value |
---|---|
December 31, 2019 | 3.941M |
September 30, 2019 | 4.548M |
June 30, 2019 | 1.848M |
March 31, 2019 | 3.687M |
December 31, 2018 | 2.708M |
September 30, 2018 | 1.754M |
June 30, 2018 | 0.335M |
March 31, 2018 | 1.916M |
December 31, 2017 | 2.172M |
September 30, 2017 | 2.194M |
June 30, 2017 | 2.267M |
March 31, 2017 | 1.434M |
December 31, 2016 | 4.652M |
September 30, 2016 | 0.657M |
June 30, 2016 | 1.042M |
March 31, 2016 | 1.206M |
December 31, 2015 | 1.36M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.007M
Minimum
Jun 2020
13.69M
Maximum
Mar 2024
6.776M
Average
7.171M
Median
Accounts Payable (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 671.30M |
Haemonetics Corp | 73.36M |
InfuSystems Holdings Inc | 9.796M |
Moderna Inc | 183.00M |
Perspective Therapeutics Inc | 6.027M |